tiprankstipranks
Trending News
More News >
Artelo Biosciences Inc (ARTL)
NASDAQ:ARTL
US Market

Artelo Biosciences (ARTL) Income Statement

Compare
473 Followers

Artelo Biosciences Income Statement

Last quarter (Q2 2023), Artelo Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Artelo Biosciences's net income was $-1.60M. See Artelo Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Sep 21Sep 20Sep 19Sep 18
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 10.29M$ 7.44M$ 4.69M$ 3.21M$ 2.34M
Depreciation and Amortization
$ 2.00K$ -2.00K$ 500.00$ 510.00$ 282.00
EBITDA
$ -10.29M$ -7.44M$ -4.71M$ -4.22M$ -2.34M
Operating Income
$ -10.29M$ -7.44M$ -4.69M$ -3.21M$ -2.34M
Other Income/Expenses
$ 204.00K$ 2.00K$ 30.91K$ 1.04M$ 0.00
Pretax Income
$ -10.08M$ -7.44M$ -4.65M$ -2.17M$ -2.34M
Net Income
$ -9.87M$ -7.44M$ -4.65M$ -2.17M$ -2.34M
Per Share Metrics
Basic EPS
$ -3.49$ -5.97$ -18.83$ -15.00$ -27.52
Diluted EPS
$ -3.49$ -5.97$ -18.83$ -15.00$ -27.52
Weighted Average Shares Outstanding
2.83M 1.25M 247.00K 144.00K 84.00K
Weighted Average Shares Outstanding (Diluted)
2.83M 1.25M 247.18K 144.83K 85.17K
Currency in USD

Artelo Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis